• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺癌远处转移的危险因素及治疗策略的研究进展。

Risk Factors of Distant Metastatic Parathyroid Carcinoma and Insights into Therapeutic Perspectives.

机构信息

Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Department of Oncology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

出版信息

Ann Surg Oncol. 2024 Oct;31(10):6865-6874. doi: 10.1245/s10434-024-15611-3. Epub 2024 Jun 15.

DOI:10.1245/s10434-024-15611-3
PMID:38879674
Abstract

BACKGROUND

Distant metastatic parathyroid carcinoma (DM-PC) is a rare but often lethal entity with limited data about prognostic indicators. We sought to investigate the risk factors, patterns, and outcomes of DM-PC.

METHODS

In this observational cohort study, 126 patients who underwent surgery for PC at a tertiary referral center from 2010 to 2023 were enrolled, among whom 38 had DMs. Univariate and multivariate Cox regression analyses were used to assess the effects of prognostic factors on DM.

RESULTS

The cumulative incidence of DM was 14.1%, 33.8%, and 66.9% at 5, 10, and 20 years in the duration of disease course, respectively. DM-PC patients suffered a worse 5-year overall survival of 37.1% compared with 89.8% in the non-DM patients (p < 0.001). DM-PC patients also suffered more previous operations (p < 0.001), higher preoperative serum calcium (p<0.001) and parathyroid hormone (PTH) levels (p < 0.001), lower frequencies of R0 resection (p < 0.001), higher rates of pathological vascular invasion (p = 0.020), thyroid infiltration (p = 0.027), extraglandular extension (p = 0.001), upper aerodigestive tract (UAT) invasion (p < 0.001), and lymph node metastasis (p < 0.001). Multivariate Cox regression revealed that non-R0 resection (HR 6.144, 95% CI 2.881-13.106, p < 0.001), UAT invasion (HR 3.718, 95% CI 1.782-7.756, p < 0.001), and higher preoperative PTH levels (HR 1.001, 95% CI 1.000-1.001, p = 0.012) were independent risk factors of DM.

CONCLUSIONS

Upper aerodigestive tract invasion and higher preoperative PTH levels might be risk factors for possible metastatic involvement of PC. R0 resection and closer surveillance should be considered in such cases to minimize the risk of DM and to optimize patient care.

摘要

背景

远处转移性甲状旁腺癌(DM-PC)是一种罕见但常致命的实体瘤,关于其预后指标的数据有限。我们旨在研究 DM-PC 的风险因素、模式和结局。

方法

在这项观察性队列研究中,纳入了 2010 年至 2023 年期间在一家三级转诊中心接受甲状旁腺癌手术的 126 名患者,其中 38 名患者患有远处转移。使用单变量和多变量 Cox 回归分析来评估预后因素对 DM 的影响。

结果

在疾病持续时间方面,DM 的累积发生率分别为 5 年时的 14.1%、10 年时的 33.8%和 20 年时的 66.9%。与非 DM 患者的 5 年总生存率 89.8%相比,DM-PC 患者的 5 年总生存率更差,为 37.1%(p<0.001)。DM-PC 患者还经历了更多的先前手术(p<0.001),更高的术前血清钙(p<0.001)和甲状旁腺激素(PTH)水平(p<0.001),更低的 R0 切除率(p<0.001),更高的病理性血管侵犯率(p=0.020),甲状腺浸润率(p=0.027),腺体外扩展率(p=0.001),上呼吸道侵犯率(p<0.001)和淋巴结转移率(p<0.001)。多变量 Cox 回归显示,非 R0 切除(HR 6.144,95%CI 2.881-13.106,p<0.001)、上呼吸道侵犯(HR 3.718,95%CI 1.782-7.756,p<0.001)和较高的术前 PTH 水平(HR 1.001,95%CI 1.000-1.001,p=0.012)是 DM 的独立危险因素。

结论

上呼吸道侵犯和较高的术前 PTH 水平可能是 PC 发生远处转移的危险因素。在这种情况下,应考虑 R0 切除和更密切的监测,以最大程度地降低 DM 的风险并优化患者的治疗。

相似文献

1
Risk Factors of Distant Metastatic Parathyroid Carcinoma and Insights into Therapeutic Perspectives.甲状旁腺癌远处转移的危险因素及治疗策略的研究进展。
Ann Surg Oncol. 2024 Oct;31(10):6865-6874. doi: 10.1245/s10434-024-15611-3. Epub 2024 Jun 15.
2
Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.甲状旁腺癌远处转移风险及其对生存的影响:高容量中心的回顾性研究。
Ann Surg Oncol. 2019 Oct;26(11):3593-3599. doi: 10.1245/s10434-019-07451-3. Epub 2019 May 20.
3
[Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].[甲状旁腺癌。基于20年经验的治疗策略]
Minerva Endocrinol. 2001 Mar;26(1):23-9.
4
Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience.单发甲状旁腺癌根治术后复发或残留的扩大整块切除术:单中心经验分析 31 例。
Ann Surg Oncol. 2022 Feb;29(2):1208-1215. doi: 10.1245/s10434-021-10962-7. Epub 2021 Oct 25.
5
Clinicopathological spectrum, management, and outcome of ectopic parathyroid carcinoma: Experience with 24 cases.异位甲状旁腺癌的临床病理特征、处理和预后:24 例经验总结。
Endocrine. 2024 Nov;86(2):813-823. doi: 10.1007/s12020-024-03964-4. Epub 2024 Jul 14.
6
A nationwide study on parathyroid carcinoma.一项关于甲状旁腺癌的全国性研究。
Acta Oncol. 2017 Jul;56(7):991-1003. doi: 10.1080/0284186X.2017.1306103. Epub 2017 Mar 31.
7
Localization and reoperation results for persistent and recurrent parathyroid carcinoma.持续性和复发性甲状旁腺癌的定位及再次手术结果
Arch Surg. 2001 Aug;136(8):878-85. doi: 10.1001/archsurg.136.8.878.
8
[Prognostic factors of lymph node-negative metastasis gastric cancer].[淋巴结阴性转移性胃癌的预后因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194.
9
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort.甲状旁腺癌的流行病学和预后:基于全国性队列的真实世界数据。
J Cancer Res Clin Oncol. 2021 Oct;147(10):3091-3097. doi: 10.1007/s00432-021-03576-9. Epub 2021 Mar 18.
10
Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.1000多例患者的甲状旁腺癌:一项基于人群水平的分析。
Surgery. 2014 Dec;156(6):1622-9; discussion 1629-30. doi: 10.1016/j.surg.2014.08.069. Epub 2014 Nov 11.

本文引用的文献

1
Evaluation of factors predicting postoperative recurrence and metastasis of parathyroid cancer: a single-center study.评估甲状旁腺癌术后复发和转移的预测因素:单中心研究。
World J Surg Oncol. 2023 Feb 3;21(1):32. doi: 10.1186/s12957-023-02912-2.
2
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases.转移性甲状旁腺癌的治疗与转归:已发表病例的系统评价与汇总分析
Front Oncol. 2022 Sep 26;12:997009. doi: 10.3389/fonc.2022.997009. eCollection 2022.
3
Tumor size rather than the thyroid invasion affects the prognosis of parathyroid carcinoma without lymph node or distant metastasis.
肿瘤大小而非甲状腺侵犯影响无淋巴结或远处转移甲状旁腺癌的预后。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4587-4594. doi: 10.1007/s00405-022-07403-w. Epub 2022 May 21.
4
Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives.甲状旁腺癌:发病率、生存分析与管理:来自监测、流行病学和最终结果(SEER)数据库的研究及对未来治疗前景的见解
Cancers (Basel). 2022 Mar 10;14(6):1426. doi: 10.3390/cancers14061426.
5
Prognostic Analysis for Patients With Parathyroid Carcinoma: A Population-Based Study.甲状旁腺癌患者的预后分析:一项基于人群的研究。
Front Neurosci. 2022 Feb 18;16:784599. doi: 10.3389/fnins.2022.784599. eCollection 2022.
6
Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience.单发甲状旁腺癌根治术后复发或残留的扩大整块切除术:单中心经验分析 31 例。
Ann Surg Oncol. 2022 Feb;29(2):1208-1215. doi: 10.1245/s10434-021-10962-7. Epub 2021 Oct 25.
7
Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study.甲状旁腺癌的临床表现、治疗和预后:NEKAR 回顾性国际多中心研究结果。
Ann Surg. 2022 Feb 1;275(2):e479-e487. doi: 10.1097/SLA.0000000000004144.
8
Intrapericardial parathyroid carcinoma: a case report.心包内甲状旁腺癌:一例报告
Endocrine. 2020 Aug;69(2):456-460. doi: 10.1007/s12020-020-02283-8. Epub 2020 Apr 4.
9
Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.甲状旁腺癌远处转移风险及其对生存的影响:高容量中心的回顾性研究。
Ann Surg Oncol. 2019 Oct;26(11):3593-3599. doi: 10.1245/s10434-019-07451-3. Epub 2019 May 20.
10
Parathyroid Carcinoma.甲状旁腺癌。
Front Horm Res. 2019;51:63-76. doi: 10.1159/000491039. Epub 2018 Nov 19.